Akari Therapeutics Plc Adr Stock (AKTX) Forecast
The Akari Therapeutics Plc Adr (AKTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $69.33, representing a +794.05% increase from the current price of $7.75. The highest analyst price target is $57.55, and the lowest is $81.10.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AKTX Price Target
Average 305.78 (+3,843% Upside)
Is Akari Therapeutics Plc Adr (AKTX) A Buy Now?
Oscillators
Buy: 1 · Sell: 2 · Neutral: 4Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, AKTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AKTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.20 indicates that AKTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 27.37 indicates that AKTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.81 indicates that AKTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 11.03 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of -103.28 indicates that AKTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term AKTX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Akari Therapeutics Plc Adr financial reports and earnings history, Akari Therapeutics Plc Adr (AKTX) stock could reach $462.37 by 2030, $2,542.55 by 2040 and $5,026.35 by 2050. See the projected annual prices until 2050 of the Akari Therapeutics Plc Adr stock below:
- Akari Therapeutics Plc Adr (AKTX) is expected to reach an average price of $969.35 in 2035, with a high prediction of $1,363.83 and a low estimate of $968.25. This indicates an +12,401% change from the last recorded price of $7.75.
- Akari Therapeutics Plc Adr (AKTX) stock is projected to chart a bullish course in 2040, with an average price target of $1,930.86, representing an +24,801% change from its current level. The forecast ranges from a conservative $1,932.06 to a sky-high $2,542.55.
- Our analysts predict Akari Therapeutics Plc Adr (AKTX) to change +40,160% by 2045, soaring from $3,140.31 to an average price of $3,121.82, potentially reaching $3,697.66. While $3,140.31 is the low estimate, the potential upside is significant.
- Akari Therapeutics Plc Adr (AKTX) stock is expected to climb by 2050, reaching an average of $4,590.25, a +59,097% change from its current level. However, a wide range of estimates exists, with high and low targets of $5,026.35 and $4,497.91, respectively, highlighting the market's uncertainty.
Akari Therapeutics Plc Adr Stock (AKTX) Year by Year Forecast
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2026
The predicted value for Akari Therapeutics Plc Adr (AKTX) in 2026 is set at an average of $12.66. Estimates vary from a peak of $57.55 to a trough of $3.02, indicating an +63.24% surge from the present price of $7.75.
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Akari Therapeutics Plc Adr (AKTX) is $310.85, with a high forecast of $678.27 and a low forecast of $24.03. This indicates an +3,909% increase from the last price of $7.75.
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2028
In 2028, Akari Therapeutics Plc Adr (AKTX) is projected to reach an average price of $696.24, with a high projection of $768.31 and a low estimate of $616.04. This indicates an +8,879% rise from the last price of $7.75.
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2029
The 2029 price forecast for Akari Therapeutics Plc Adr Stock (AKTX) is $589.65 on average, with a high prediction of $660.58 and a low estimate of $459.46. This represents an +7,504% increase from the previous price of $7.75.
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2030
Akari Therapeutics Plc Adr Stock (AKTX) is expected to reach an average price of $402.82 in 2030, with a high forecast of $462.37 and a low forecast of $315.20. This signifies an +5,095% surge from the last price of $7.75.
